跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
恩临 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rilpivirine Tablets
Approved
化学药品
Rilpivirine Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Apr 29, 2022
Approval ID
8H1Or9FhNeK
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8H1Or9FhNeK
Approval Number
国药准字HJ20171075
Generic Name
利匹韦林片
Generic Name En
Rilpivirine Tablets
Trade Name
恩临
Drug Type
化学药品
Dosage Form
片剂
Strength
25mg
Reg Date
2022-04-29
Expired Date
2027-04-28
Company Name
Janssen-Cilag International NV
Production Company Name
Janssen-Cilag SpA
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/janssen-cilag-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 29, 2022
Approval ID
8H1Or9FhNeK
Type
化学药品
Back to NMPA Approvals